• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Ifosfamide

Ifosfamide

Product ID I2056
Cas No. 3778-73-2
Purity ≥98%
Product Unit SizeCostQuantityStock
25 mg $61.00 In stock
50 mg $72.00 In stock
250 mg $133.00 In stock
1 g $274.00 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Ifosfamide is a nitrogen mustard alkylator that exhibits anticancer chemotherapeutic activity. Ifosfamide is clinically used to treat various cancers. Because ifosfamide is very cytotoxic, it is often co-administered with cytoprotective agents such as MESNA.

Product Info

Cas No.

3778-73-2

Purity

≥98%

Formula

C7H15Cl2N2O2P

Formula Wt.

261.09

Chemical Name

N, 3-Bis(2-chloroethyl)-tetrahydro-2H-1,3,2-oxaza- phosphorin-2-amine 2-oxide

IUPAC Name

N,3-bis(2-chloroethyl)-2-oxo-1,3,2λ5-oxazaphosphinan-2-amine

Synonym

Holoxan, Ifex, Ifomide, Isoendoxan, Isophosphamide, Mitoxana

Melting Point

39-41°C, 51.0°C

Solubility

100mg/mL in water.

Appearance

White Crystal Powder

Shipping and Storage

Store Temp

Ambient

Ship Temp

Ambient

Downloads

MSDS

I2056 MSDS PDF

Info Sheet

I2056 Info Sheet PDF

References

Vincenzi B, Frezza AM, Santini D, et al. New therapies in soft tissue sarcoma. Expert Opin Emerg Drugs. 2010 Jun;15(2):237-48. PMID: 20465449.

Nissim I, Horyn O, Daikhin Y, et al. Ifosfamide-induced nephrotoxicity: mechanism and prevention. Cancer Res. 2006 Aug 1;66(15):7824-31. PMID: 16885387.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • P0278

    Patulin

    Mycotoxin produced by Penicillum and Aspergillu...

    ≥98%
  • G0106

    Gabapentin

    GABA analog; GABA potentiator, adenosine A1 ago...

    ≥98%
  • S8243

    Sulbactam Sodium

    β-lactamase inhibitor.

    ≥98%
  • S0500

    SB-203580

    p38 MAPK inhibitor.

    ≥98%
  • L0362

    Lapatinib free base

    Inhibitor of EGFR/HER2 (ErbB2).

    ≥99%
  • T0094

    2′,7-Bisacetyltaxol

    Taxane synthesis intermediate.

    ≥96%
  • B242042

    BGB-283

    Dual RAF/EGFR inhibitor.

    ≥98%
  • C9880

    Cytochalasin C

    Mycotoxin produced by Aspergillus; actin polyme...

    ≥98%, TLC
  • C9613

    Cyclosporin D

    Cyclosporin metabolite; weak calmodulin inhibit...

    ≥98%
  • S164098

    Seco-rapamycin

    Rapamycin analog

    ≥73%
  • M4200

    MK-0752

    γ-Secretase inhibitor.

    ≥98%
  • M1560

    Methyl Caffeate

    Polyphenol found in species of Solanum and Magn...

    ≥98%
  • A980005

    AZ-5104

    Inhibitor of EGFR.

    ≥98%
  • T5846

    Tolfenamic Acid

    NSAID; COX-1/2 inhibitor.

    ≥98%
  • L0528

    LBH-589

    HDAC1/2/3/11 inhibitor.

    ≥98%
  • A5279

    Angiotensin II (1-4), human

    Endogenous peptide fragment, involved in vasoco...

    ≥95%
  • A7203

    AS-703026

    MEK1/2 inhibitor.

    ≥98%
  • R3321

    Rifaximin

    Rifampicin derivative; DNA-dependent RNA polyme...

    ≥98%
  • N1656

    D-(+)-Neopterin

    Endogenous pteridine metabolite of GTP.

    ≥98%
  • L0400

    LB-100

    PP2A inhibitor.

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2026 LKT Laboratories, All Rights Reserved - Products for research use only